PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26324N0167DO oy1 FARGO chemistry immunochemistry base+4 — Roche Diagnostics Corp

Roche Diagnostics Corp holds $245.9M across 1,391 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36C26323A0026. Competition previously drew 5 offers. Set-aside status: NONE. PoP ended Sep 30, 2024 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Network Contract Office 23 (36C263)
Awarding office
Roche Diagnostics Corp
Recipient
Sep 30, 2024
PoP end
$410K
Obligated
$565K
Potential
334516
NAICS
6640
PSC
NONE
Set-aside
5 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Roche Diagnostics Corp — $90

Contract facts

NONE
Contract number36C26324N0167
Also listed as36C263-24-N-0167
Also listed as36C26323A0026-36C26324N0167
AgencyNetwork Contract Office 23 (36C263)
Awarding officeNetwork Contract Office 23 (36C263)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentRoche Diagnostics Corp
CAGE51169
UEIJDMDFEZBYH36
NAICS334516

No full NAICS 334516 intel page yet. Browse NAICS intelligence

PSC6640
Parent IDIQ / IDV36C26323A0026
Place of performanceINDIANAPOLIS IN
Pricing typeFirm Fixed Price
Extent competedCompeted Under SAP
PoP startOct 1, 2023
PoP end (current)Sep 30, 2024
PoP end (w/ options)May 31, 2028
Obligated$410K
Current value$565K
Potential value$565K

DO OY1 FARGO CHEMISTRY IMMUNOCHEMISTRY BASE+4 is a federal NONE award for Network Contract Office 23 (36C263) held by Roche Diagnostics Corp. Estimated value $565K ($410K obligated). Current period of performance ends Sep 30, 2024 (potential May 31, 2028). Last award drew 5 bidders. Place of performance: INDIANAPOLIS IN.

DO OY1 FARGO CHEMISTRY IMMUNOCHEMISTRY BASE+4

Recompete timing

Public
Past PoP end (690 days ago)

Current PoP ended Sep 30, 2024 (690 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Roche Diagnostics Corp$245.9M obligated across 1,391 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($245.9M) · all agencies
Department of Veterans Affairs (VA)$154.1M · 63%Department of Defense (DOD)$77.5M · 32%Department of Health and Human Services (HHS)$10.4M · 4%Department of Justice (DOJ)$3.0M · 1%
Open full company profile

Related awards

Same parent · incumbent
36C26225N0151
CHEMISTRY IMMUNOASSAY SYSTEM CPT
$5.9M
Aug 31, 2026
36C25025N1021
FSS-BPA ROCHE COBAS 4800 REAGENTS, CONSUMABLES, CONTROLS.
$600K
Aug 31, 2026
FA480321F0055
ROCHE COVID TEST KITS
$159K
Aug 31, 2026
36C25025N1000
COBA REAGENTS/CONSUMABLES
$135K
Aug 31, 2026
36C25726P0473
BENCHMARK ULTRA PLUS
$132K
Aug 31, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C26324N0167?

36C26324N0167 (DO oy1 FARGO chemistry immunochemistry base+4) is a Network Contract Office 23 (36C263) award with a potential value of $565K, currently held by Roche Diagnostics Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C263-24-N-0167?

36C263-24-N-0167 is the dashed form of PIID 36C26324N0167 (DO oy1 FARGO chemistry immunochemistry base+4), held by Roche Diagnostics Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26324N0167?

Network Contract Office 23 (36C263) awarded 36C26324N0167 to Roche Diagnostics Corp (potential $565K).

Who is the incumbent on 36C26324N0167?

Roche Diagnostics Corp is the incumbent with $245.9M across 1391 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2024.

When does Roche Diagnostics Corp’s 36C26324N0167 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C26324N0167